Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
Author:
Funder
National Institutes of Health
NIH Office of the Director
Publisher
Frontiers Media SA
Subject
Clinical Neurology,Neurology
Reference83 articles.
1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010;Ostrom;Neuro Oncol.,2013
2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med.,2005
3. Glioblastoma multiforme: a review of therapeutic targets;Kanu;Expert Opin Ther Targets,2009
4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol.,2009
5. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1;Verhaak;Cancer Cell,2010
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification and validation of drugs for repurposing in Glioblastoma: a computational and experimental workflow;2024-05-02
2. Etoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers;Colloid Journal;2023-10
3. Etoposide-Loaded Colloidal Delivery Systems Based on Biodegradable Polymeric Carriers;Коллоидный журнал;2023-09-01
4. MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II;Molecules;2023-07-24
5. Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors;ACS Pharmacology & Translational Science;2022-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3